Quantitative Systematic Strategies Cut Gap Inc/The (GPS) Position by $2.42 Million; Share Price Declined; As Biogen (BIIB) Stock Declined, Gruss & Co Raised by $1.57 Million Its Stake

February 22, 2018 - By Louis Casey

Gruss & Co Inc increased its stake in Biogen Inc (BIIB) by 125% based on its latest 2017Q3 regulatory filing with the SEC. Gruss & Co Inc bought 5,000 shares as the company’s stock declined 13.45% while stock markets rallied. The institutional investor held 9,000 shares of the biological products (no diagnostic substances) company at the end of 2017Q3, valued at $2.82M, up from 4,000 at the end of the previous reported quarter. Gruss & Co Inc who had been investing in Biogen Inc for a number of months, seems to be bullish on the $60.53B market cap company. The stock decreased 0.47% or $1.35 during the last trading session, reaching $286.1. About 1.92 million shares traded or 41.29% up from the average. Biogen Inc. (NASDAQ:BIIB) has risen 4.94% since February 22, 2017 and is uptrending. It has underperformed by 11.76% the S&P500.

Quantitative Systematic Strategies Llc decreased its stake in Gap Inc/The (GPS) by 76.54% based on its latest 2017Q3 regulatory filing with the SEC. Quantitative Systematic Strategies Llc sold 83,519 shares as the company’s stock declined 8.95% while stock markets rallied. The institutional investor held 25,600 shares of the consumer services company at the end of 2017Q3, valued at $756,000, down from 109,119 at the end of the previous reported quarter. Quantitative Systematic Strategies Llc who had been investing in Gap Inc/The for a number of months, seems to be less bullish one the $12.53 billion market cap company. The stock increased 1.93% or $0.61 during the last trading session, reaching $32.22. About 4.56M shares traded. The Gap, Inc. (NYSE:GPS) has risen 28.94% since February 22, 2017 and is uptrending. It has outperformed by 12.24% the S&P500.

Since January 9, 2018, it had 0 buys, and 2 selling transactions for $2.31 million activity. $1.92 million worth of Biogen Inc. (NASDAQ:BIIB) was sold by PANGIA ROBERT W.

Investors sentiment increased to 1.13 in 2017 Q3. Its up 0.25, from 0.88 in 2017Q2. It increased, as 59 investors sold BIIB shares while 283 reduced holdings. 96 funds opened positions while 292 raised stakes. 181.16 million shares or 0.28% more from 180.66 million shares in 2017Q2 were reported. California Pub Employees Retirement holds 0.23% or 503,518 shares. 1.10M were reported by Morgan Stanley. Stifel holds 0.19% or 177,094 shares in its portfolio. Endurant Mgmt Lp holds 3.78% of its portfolio in Biogen Inc. (NASDAQ:BIIB) for 39,817 shares. Jump Trading Ltd Liability Corp accumulated 0% or 81 shares. Finemark Financial Bank, a Florida-based fund reported 3,924 shares. Eqis Capital Mngmt, California-based fund reported 6,738 shares. South State has invested 0.05% of its portfolio in Biogen Inc. (NASDAQ:BIIB). Bourgeon Cap Management holds 13,726 shares or 2.53% of its portfolio. Moreover, Schroder Inv Management Group has 0.27% invested in Biogen Inc. (NASDAQ:BIIB) for 495,471 shares. Wedge Cap Mngmt L Lp Nc holds 135,083 shares. Alabama-based Weiss Multi has invested 0.35% in Biogen Inc. (NASDAQ:BIIB). E&G Advisors LP has 2,120 shares. Greenleaf Tru owns 0.01% invested in Biogen Inc. (NASDAQ:BIIB) for 831 shares. Waverton Mngmt Limited holds 5.3% in Biogen Inc. (NASDAQ:BIIB) or 272,602 shares.

Among 33 analysts covering Biogen Idec Inc. (NASDAQ:BIIB), 24 have Buy rating, 0 Sell and 9 Hold. Therefore 73% are positive. Biogen Idec Inc. had 113 analyst reports since July 23, 2015 according to SRatingsIntel. The rating was upgraded by UBS to “Neutral” on Monday, June 19. The stock has “Hold” rating by Jefferies on Tuesday, September 6. Canaccord Genuity maintained Biogen Inc. (NASDAQ:BIIB) on Wednesday, January 24 with “Hold” rating. Robert W. Baird maintained Biogen Inc. (NASDAQ:BIIB) on Thursday, September 28 with “Hold” rating. The stock of Biogen Inc. (NASDAQ:BIIB) has “Strong-Buy” rating given on Tuesday, September 1 by Raymond James. The stock of Biogen Inc. (NASDAQ:BIIB) earned “Market Perform” rating by BMO Capital Markets on Wednesday, July 26. The stock of Biogen Inc. (NASDAQ:BIIB) earned “Buy” rating by Bank of America on Wednesday, October 18. BMO Capital Markets maintained it with “Market Perform” rating and $377 target in Wednesday, September 13 report. The rating was maintained by Stifel Nicolaus with “Buy” on Monday, October 23. The rating was maintained by Piper Jaffray on Thursday, January 18 with “Buy”.

Among 33 analysts covering The Gap Inc. (NYSE:GPS), 4 have Buy rating, 4 Sell and 25 Hold. Therefore 12% are positive. The Gap Inc. had 162 analyst reports since August 5, 2015 according to SRatingsIntel. The stock of The Gap, Inc. (NYSE:GPS) has “Sell” rating given on Friday, June 3 by Deutsche Bank. The firm earned “Buy” rating on Friday, November 20 by Stifel Nicolaus. Jefferies maintained the stock with “Buy” rating in Wednesday, August 16 report. Robert W. Baird maintained The Gap, Inc. (NYSE:GPS) rating on Thursday, December 21. Robert W. Baird has “Hold” rating and $35.0 target. Cantor Fitzgerald maintained The Gap, Inc. (NYSE:GPS) rating on Friday, December 4. Cantor Fitzgerald has “Hold” rating and $26 target. As per Tuesday, May 23, the company rating was maintained by Morgan Stanley. The stock of The Gap, Inc. (NYSE:GPS) has “Hold” rating given on Thursday, October 1 by S&P Research. On Friday, November 20 the stock rating was maintained by FBR Capital with “Mkt Perform”. As per Friday, August 19, the company rating was maintained by Robert W. Baird. The firm has “Neutral” rating given on Friday, November 18 by Mizuho.

Analysts await The Gap, Inc. (NYSE:GPS) to report earnings on March, 1 after the close. They expect $0.58 earnings per share, up 13.73% or $0.07 from last year’s $0.51 per share. GPS’s profit will be $225.54M for 13.89 P/E if the $0.58 EPS becomes a reality. After $0.58 actual earnings per share reported by The Gap, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Since September 1, 2017, it had 0 buys, and 5 insider sales for $18.96 million activity. 1,935 shares valued at $49,906 were sold by Syngal Sonia on Thursday, September 7. Shares for $192,921 were sold by Hyder Brent. FISHER WILLIAM SYDNEY had sold 666,849 shares worth $18.67 million.

Investors sentiment decreased to 0.96 in Q3 2017. Its down 0.21, from 1.17 in 2017Q2. It turned negative, as 44 investors sold GPS shares while 144 reduced holdings. 60 funds opened positions while 120 raised stakes. 204.26 million shares or 4.13% less from 213.05 million shares in 2017Q2 were reported. Commonwealth Equity holds 16,767 shares. Wolverine Asset Mngmt Ltd Liability Com reported 1,390 shares stake. Dupont Mngmt holds 0.02% of its portfolio in The Gap, Inc. (NYSE:GPS) for 31,044 shares. Van Eck Associate Corp owns 26,476 shares for 0% of their portfolio. Great West Life Assurance Company Can, a Manitoba – Canada-based fund reported 440,893 shares. Moreover, Royal Bancorporation Of Canada has 0.01% invested in The Gap, Inc. (NYSE:GPS). Bankshares Of Nova Scotia, a Ontario – Canada-based fund reported 78,744 shares. Lazard Asset Mngmt Ltd reported 12,613 shares. State Bank Of America De stated it has 972,823 shares. Envestnet Asset Mngmt Inc owns 0.01% invested in The Gap, Inc. (NYSE:GPS) for 74,049 shares. Johnson Investment Counsel holds 0.01% of its portfolio in The Gap, Inc. (NYSE:GPS) for 15,194 shares. Citigroup Inc has 0.01% invested in The Gap, Inc. (NYSE:GPS). Fifth Third Natl Bank stated it has 0% in The Gap, Inc. (NYSE:GPS). Gulf Intl Bancshares (Uk) Limited stated it has 75,413 shares. Us Commercial Bank De holds 53,326 shares or 0.01% of its portfolio.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>